Sellbyville, Delaware, Aug. 20, 2018 (GLOBE NEWSWIRE) --
Global In-vitro Diagnostics Market outlook is poised to surpass USD 92 billion by 2024, says a new Global Market Insights, Inc. report featuring key industry trends across the product, service type, technology, application, end-user, and regional landscape.
According to the report, rising adoption of technologically advanced diagnostic equipment for enhanced convenience and accuracy is set to augment in-vitro diagnostics industry share in the ensuing years.
In-vitro diagnostics market from the oncology application segment is expected to register a y-o-y growth of 7.1% over 2018-2024. The rising prevalence of cancer and increasing demand to come up with effective diagnosis and treatment have been primarily influencing the segment growth.
Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/2820
In terms of the regional landscape, the U.S. accounted for a remarkable 89.7% of the regional in-vitro diagnostics market share in 2017 and is projected to continue its growth trajectory over the coming six years. Rising cases pertaining to viral infections, chronic diseases, and hepatitis C, which demand advanced diagnostic methods & devices are expected to impel the regional growth.
The key players profiled in the report are Qiagen, The Danaher Corporation, Cepheid Inc., bioMérieux, Grifols, S.A., Bio-Rad Laboratories, Inc., Luminex Corporation, The Sorin Group, Johnson & Johnson, Becton-Dickinson and Company, Roche Diagnostics, Thermo Fisher Scientific, and Siemens AG. The companies have been profiled in terms of their SWOT analysis, product portfolio, and strategic outlook.
Browse key industry insights spread across 350 pages with 284 market data tables & 11 figures & charts from the report, “In-vitro Diagnostics Market” in detail along with the table of contents:
https://www.gminsights.com/industry-analysis/in-vitro-diagnostics-market
Scope of the In-Vitro Diagnostics Market report:
- Product landscape: Reagents & Kits, Instruments
- Service type landscape: Data Management Software, Services
- Technology landscape: Clinical Chemistry, Immunoassay/Immunochemistry, Hematology, Urinalysis, Microbiology, Molecular Diagnostics, Coagulation & Hemostasis, Others
- Application landscape: Oncology, Infectious Diseases, Autoimmune Diseases, Diabetes, Nephrology, Cardiology, Drug Testing/Pharmacogenomics, Others
- End-user landscape: Hospitals, Laboratories, Point-Of-Care Testing, Academic Institutes, Others
- Regional landscape: Canada, U.S., Italy, France, UK, Spain Germany, Russia, Japan, China, India, Australia, Mexico, Brazil, Saudi Arabia, UAE, South Africa
Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/2820
Browse Related Reports:
- In-Vitro Colorectal Cancer Screening Tests Market Size 2017 – 2024
In-Vitro Colorectal Cancer Screening Tests Market outlook was valued over USD 785 million in 2016 and is anticipated to witness growth of over 5.0% CAGR from 2017 to 2024. Rising incidences of cancer, growing demand for non-invasive disease diagnosis methods along with technological advancements in cancer screening techniques will drive the market.
https://www.gminsights.com/industry-analysis/in-vitro-colorectal-cancer-screening-tests-market-report
- Molecular Diagnostics Market Size 2018 – 2024
Molecular Diagnostics Market revenue was valued at USD 7.2 billion in 2017 and is expected to witness more than 8.5% CAGR from 2018 to 2024. Increasing geriatric population across the globe will render significant positive impact on global market growth over the forecast timeframe.
https://www.gminsights.com/industry-analysis/molecular-diagnostics-market-report
About Global Market Insights:
Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.